These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9893735)

  • 1. Divergent effects of ACE-inhibition and calcium channel blockade on NO-activity in systemic and renal circulation in essential hypertension.
    Dijkhorst-Oei LT; Beutler JJ; Stroes ES; Koomans HA; Rabelink TJ
    Cardiovasc Res; 1998 Nov; 40(2):402-9. PubMed ID: 9893735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1-induced vasopressor responses in essential hypertension.
    Kaasjager KA; Koomans HA; Rabelink TJ
    Hypertension; 1997 Jul; 30(1 Pt 1):15-21. PubMed ID: 9231815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
    Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans.
    Dijkhorst-Oei LT; Rabelink TJ; Boer P; Koomans HA
    Hypertension; 1997 May; 29(5):1192-8. PubMed ID: 9149686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension.
    On YK; Kim CH; Oh BH; Lee MM; Park YB
    Hypertens Res; 2002 May; 25(3):365-71. PubMed ID: 12135314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension.
    Higashi Y; Oshima T; Sasaki S; Nakano Y; Kambe M; Matsuura H; Kajiyama G
    Hypertension; 1998 Jul; 32(1):16-24. PubMed ID: 9674632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide-endothelin-1 interaction in humans.
    Ahlborg G; Lundberg JM
    J Appl Physiol (1985); 1997 May; 82(5):1593-600. PubMed ID: 9134909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.
    Stamler JS; Loh E; Roddy MA; Currie KE; Creager MA
    Circulation; 1994 May; 89(5):2035-40. PubMed ID: 7514109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nos inhibition on retinal arterial and capillary circulation in early arterial hypertension.
    Michelson G; Wärntges S; Harazny J; Oehmer S; Delles C; Schmieder RE
    Retina; 2006 Apr; 26(4):437-44. PubMed ID: 16603964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resetting baroreceptors to a lower arterial pressure level by enalapril avoids baroreflex mediated activation of sympathetic nervous system by nifedipine.
    Zhang W; Wang Z
    Life Sci; 2001 May; 68(25):2769-79. PubMed ID: 11432443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
    Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
    Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial factors and microvascular hypertensive disease.
    Rizzoni D; Agabiti-Rosei E
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S15-8. PubMed ID: 11811369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
    Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A
    J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
    Kvam FI; Ofstad J; Iversen BM
    Am J Physiol; 1998 Oct; 275(4):F576-84. PubMed ID: 9755129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension.
    Lyons D; Webster J; Benjamin N
    J Hypertens; 1994 Sep; 12(9):1047-52. PubMed ID: 7852748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.